Conjugated estrogens and bazedoxifene.

Article Details

Citation

Cada DJ, Baker DE

Conjugated estrogens and bazedoxifene.

Hosp Pharm. 2014 Mar;49(3):273-83. doi: 10.1310/hpj4903-273.

PubMed ID
24715748 [ View in PubMed
]
Abstract

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. A drug class review is now published monthly with The Formulary Monograph Service. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, call The Formulary at 800-322-4349. The March 2014 monograph topics are umeclidinium and vilanterol inhalation powder, sucroferric oxyhydroxide, luliconazole, edoxaban, and secukinumab. The DUE/MUE is on fentanyl transdermal system.

DrugBank Data that Cites this Article

Drugs
Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
Conjugated estrogensEstrogen receptor betaProteinHumans
Yes
Agonist
Details
Drug Carriers
DrugCarrierKindOrganismPharmacological ActionActions
Conjugated estrogensSerum albuminProteinHumans
No
Binder
Details
Conjugated estrogensSex hormone-binding globulinProteinHumans
No
Binder
Details
Drug Reactions
Reaction
Conjugated estrogens
DB00286
    Details
    Drug Interactions
    DrugsInteraction
    Bazedoxifene
    Phenytoin
    The serum concentration of Bazedoxifene can be decreased when it is combined with Phenytoin.
    Bazedoxifene
    Fosphenytoin
    The serum concentration of Bazedoxifene can be decreased when it is combined with Fosphenytoin.
    Bazedoxifene
    Carbamazepine
    The serum concentration of Bazedoxifene can be decreased when it is combined with Carbamazepine.